Personnel Moves Archives - Page 3 of 42

Former Tandem CCO joins Ascensia as president of CGM

Ascensia Diabetes Care parent company PHC Holdings and Senseonics announced today that Ascensia named Brian Hansen its president of CGM.

Hansen’s appointment to the newly created role at the global distributor of Senseonics’ Eversense CGM went into effect today, Feb. 6.

Responsibilities for Hansen include the global commercialization and growth of the Eversense system. The fully implantable CGM allows for the continuous measurement of glucose levels for up to six months. With longevity, it also offers features like a removable transmitter, discreet on-body vibe alerts, accuracy and a smartphone app.

Hansen previously served as chief commercial officer at insulin pump maker Tandem Diabetes Care.

Get the full story at our sister site, Drug Delivery Business News.

Globus Medical promotes new COO from within

Keith Pfeil. [Image courtesy of Globus Medical]Globus Medical (NYSE: GMED) + announced that it promoted CFO Keith Pfeil to the position of chief operating officer (COO).

Pfeil first took over the CFO post in August 2019. Globus Medical hopes his new expanded role can help further drive its strategic roadmap through business and operational planning in addition to financial performance management.

He continues reporting to Globus President and CEO Dan Scavilla.

“I am excited to take on the role of COO in addition to my current role of CFO, as Globus continues to build on the momentum we have created to transform our industry and help change more patient lives around the globe,” said Pfeil. “I look forward to continuing to work with our board of directors, Dan and the executive leadership team to further realize our growth potential.”

His responsibilities include overseeing all day-to-d…

LivaNova picks longtime J&J exec as new CEO

New LivaNova CEO Vladimir Makatsaria. [Image from LinkedIn]LivaNova (Nasdaq: LIVN) + announced today that its board of directors appointed Vladimir A. Makatsaria as its CEO and a member of the board.

The appointment goes into effect on March 1, 2024. He succeeds Bill Kozy, who took over the CEO role on an interim basis in April 2023 when Damien McDonald resigned from the corner office.

Makatsaria most recently served as company group chair at Johnson & Johnson MedTech. He took up that position in October 2018 to lead the company’s global Ethicon surgery business. Overall, he spent more than 27 years at the medtech giant, including stints as the company’s group chair for medical devices in Asia Pacific and as the J&J chair for China.

“Vlad is a respected leader in the medical device industry with a proven reputation for delivering results, driving innovation and building great teams,” said Bill K…

Inspire Medical CEO takes over as board chair

Inspire Medical Systems (NYSE:INSP) announced today that Marilyn Carlson Nelson retired as chair of the company’s board of directors.

The Minneapolis-based sleep apnea treatment developer appointed current CEO Timothy Herbert to the additional role of board chair. Herbert’s appointment goes into effect after the company’s annual meeting of stockholders on May 2, 2024.

Nelson became the chair of the Inspire board in 2018 following the passing of her husband. Dr. Glen D. Nelson had been the company’s original board chair.

Herbert, the founder of Inspire, has held the post of president and CEO since May 2007. He brings decades of expertise in the medical device industry.

“Marilyn has had a profound impact on our business and our employees through her many years on the board,” Herbert said in a news release. “I want to personally thank Marilyn for her leadership and mentoring not only myself but the entire team ove…

Boston Scientific picks new investor relations VP, chief accounting officer

Boston Scientific (NYSE: BSX) + announced that it appointed a new SVP of investor relations and a new chief accounting officer.

In an SEC filing, the company announced the appointments, made on Jan. 26. Jonathan Monson takes over as SVP, investor relations, effective March 1, 2024. Monson currently serves as SVP, global controller and chief accounting officer, positions he took up in July 2019.

With Monson departing those roles, Boston Scientific chose Emily Woodworth as SVP, global controller and chief accounting officer. Woodworth takes over on March 1 as well. She currently serves as VP of finance and controller of the company’s Urology unit, having also taken on those posts in July 2019.

Before her current role, Woodworth was director of global technical accounting and external reporting from April 2016 until July 2019. Prior to that, she served as controller and finance director for Boston Scientific&…

Augmedics CEO takes over corner office at CVRx

Incoming CVRx CEO Kevin Hykes. [Image courtesy of Revival Healthcare Capital]CVRx (Nasdaq:CVRX) announced today that it appointed Kevin Hykes as its new president and CEO, effective Feb. 12.

Hykes already has familiarity with the Minneapolis-based neurostimulation technology developer, having joined its board in December 2022. He will continue to serve on the board, with CEO Nadim Yared set to retire from the company and resign his board seat.

Yared agreed to consult with the company to ensure a seamless transition as Hykes takes over the corner office.

“I am excited to be stepping into the role of CEO after over a year as an independent board member. I have spent the last 32 years commercializing disruptive medical devices like Barostim with the goal of bringing them to standard of care and making a difference in patient’s lives,” said Hykes. “The team has done a tremendous job demonstrating a strong clinical benefit and driving commercial adoption of Baro…

Former Insulet exec joins Imperative Care as COO amid number of leadership moves

Imperative Care COO Chuck Alpuche [Image from Alpuche’s LinkedIn page]Imperative Care announced today that it appointed Chuck Alpuche as its new COO along with a slew of leadership changes.

The stroke care company named Peter Griffin as SVP of operations, Scott Elliott as chief legal officer and Daniel Davis as chief strategy officer, too.

Fred Khosravi, Imperative Care CEO and chair, said the moves come amid an “inflection point of operational scale and excellence.” In August, Imperative Care implemented a new organizational structure designed to accelerate growth.

The company now stands as the parent company of four businesses. These businesses all share a common goal of bringing care to those affected by stroke and other ischemic diseases.

“Chuck and Peter together have made an indelible impact in elevating the treatment of diabetes, and they will turn their attention to doing the same for stroke and thrombectomy care,” Kho…

Longtime Inspire Medical board member Dr. Jerry Griffin to retire

Inspire Medical Systems (NYSE:INSP) announced today that Dr. Jerry C. Griffin intends to retire from its board of directors.

Griffin plans to retire at the conclusion of the company’s annual meeting of stockholders on May 2, 2024.

The longtime director joined the Inspire board in 2008 as one of the original board members. He joined before the company’s initial Series A financing round.

Most recently, Griffin served on the board’s Nominating and Corporate Governance Committee. He departs the board shortly after Inspire brought on another experienced member in Dr. Myriam J. Curet. Curet, whose appointment went into effect on Dec. 21, currently serves as EVP and chief medical officer at surgical robotics pioneer Intuitive Surgical.

“After sixteen years of service, we announce the retirement of Dr. Griffin from our board of directors. His contributions to our board and organization are innumerable and we are grateful for the dedicati…

Lantheus announces a new CEO

Lantheus Holdings’ incoming CEO Brian Markison [Image courtesy of Lantheus]

Radiopharmaceutical-focused Lantheus Holdings (NASDAQ: LNTH) announced today that current board chair and industry veteran Brian Markison will become the company’s CEO, effective March 1.

Markison succeeds Mary Anne Heino, who is retiring from Lantheus’ corner office after leading the company for nine years. Heino will serve as board chair after March 1. Board member Julie McHugh will become lead independent director effective immediately.

“Brian is perfectly suited to lead Lantheus as the company enters its next growth phase. He has held the chair role for more than 10 years and in that role has overseen company strategy. He knows our exceptional executive team well and brings decades of leadership experience as the CEO of public companies with development, commercialization and manufacturing expertise, includin…

Former Boston Scientific exec joins pulsed field ablation company Mirai Medical’s board

New Mirai Medical non-executive board director David Pierce. [Image from Boston Scientific]Mirai Medical announced today that it appointed former Boston Scientific (NYSE: BSX) + executive David A. Pierce as a non-executive board director.

Pierce spent 31 years at Boston Scientific, gaining valuable experience in product commercialization, market access and clinical change management. Much of his work came in the gastrointestinal endoscopy space, providing expertise he can now bring to Mirai Medical. Pierce retired from his post as EVP and president of medsurg and endoscopy at Boston Scientific in July 2022.

“We are thrilled to welcome David to our board,” Mirai Medical CEO Declan Soden said in a news release. “His extensive experience at Boston Scientific, coupled with his deep knowledge of the industry, will undoubtedly play a pivotal role in guiding Mirai Medical’s strategic direction. As leaders in pu…

Getinge appoints Agneta Palmér as CFO

Agneta Palmér [Image courtesy of Getinge]Getinge announced today that it appointed Agneta Palmér as chief financial officer.

Palmér will succeed Lars Sandström, who is leaving Getinge for a new opportunity outside of the company. Palmér most recently was the EVP of operations services at Getinge and has been with the company since 2018.

”I am very pleased that Agneta is taking over as CFO. She has extensive experience from finance in global operations and has in-depth knowledge of Getinge’s business. In addition, in her previous role, she has been involved in establishing our current finance organization, which she will now continue to develop,” Getinge President and CEO Mattias Perjos said in a news release.

Before becoming EVP of operations services, Palmér was VP of corporate control at Getinge. She held similar roles at AB Volvo.

Her appointment takes effect at the end of March when Sandström steps down.

”Lars has contributed …

Insulet has new directors as former CEO is set to retire from board

Shacey Petrovic

Insulet (Nasdaq: PODD) + announced today that it named a duo of new board directors with high-profile figures set to retire.

Acton, Massachusetts-based Insulet appointed Flavia Pease and Timothy Stonesifer to its board. Former CEO Shacey Petrovic, along with Corinne Nevinny, intend to retire from the board in May.

Petrovic spent more than seven years as CEO at the automated insulin delivery technology developer. She stepped down from the corner office in May 2022 and remained on the board as Jim Hollingshead took over as CEO. Petrovic spent nearly six years on the board at Insulet, while Nevinny offered five years of service to the board.

Get the full story at our sister site, Drug Delivery Business News.